AI tool to help diagnose skin cancer in primary care
Part of Cancer, Skin clinical trials.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are going to your primary care doctor to have a skin lesion checked for skin cancer.
- You are willing and able to give permission to be in the study.
- Your skin type is not very dark brown or black (types V or VI on the Fitzpatrick scale).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artificial-intelligence smartphone app that helps spot possible skin cancer by looking at skin spots (lesions). You may benefit by getting guidance on whether your new or changing mole needs closer attention.
This study tests a way for doctors to send clear images of your skin spot to be reviewed remotely using teledermoscopy (digital images of the skin). It may help speed up specialist input and improve how skin spots are assessed.
This study tests if a telemedicine tool can help find skin tumors early. It may be a good fit if you have a suspicious spot and light skin that burns easily.
This trial tests an artificial intelligence system designed to spot skin cancer early. You may be able to join if you are an adult with a suspicious skin spot and can give permission to participate.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This trial tests a smartphone-based AI system that helps diagnose skin conditions. It may offer faster, more accurate diagnosis for people visiting a walk-in clinic with a skin problem.
Hear when a new Skin Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.